Literature DB >> 27037542

Financial Neutrality for Living Organ Donors: Reasoning, Rationale, Definitions, and Implementation Strategies.

R Hays1, J R Rodrigue2, D Cohen3, G Danovitch4, A Matas5, J Schold6, D LaPointe Rudow7.   

Abstract

In the United States, live organ donation can be a costly and burdensome undertaking for donors. While most donation-related medical expenses are covered, many donors still face lost wages, travel expenses, incidentals, and potential for future insurability problems. Despite widespread consensus that live donors (LD) should not be responsible for the costs associated with donation, little has changed to alleviate financial burdens for LDs in the last decade. To achieve this goal, the transplant community must actively pursue strategies and policies to eliminate unreimbursed out-of-pocket costs to LDs. Costs should be more appropriately distributed across all stakeholders; this will also make live donation possible for people who, in the current system, cannot afford to proceed. We propose the goal of LD "financial neutrality," offer an operational definition to include the coverage/reimbursement of all medical, travel, and lodging costs, along with lost wages, related to the act of donating an organ, and guidance for consideration of medical care coverage, and wage and other expense reimbursement. The intent of this report is to provide a foundation to inform discussion within the transplant community and to advance initiatives for policy and resource allocation. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  donors and donation: living; economics; ethics and public policy; kidney transplantation/nephrology; kidney transplantation: living donor; law/legislation; liver transplantation/hepatology; liver transplantation: living donor

Mesh:

Year:  2016        PMID: 27037542     DOI: 10.1111/ajt.13813

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  14 in total

Review 1.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

2.  Racial differences in completion of the living kidney donor evaluation process.

Authors:  Komal Kumar; James M Tonascia; Abimereki D Muzaale; Tanjala S Purnell; Shane E Ottmann; Fawaz Al Ammary; Mary G Bowring; Anna Poon; Elizabeth A King; Allan B Massie; Eric K H Chow; Alvin G Thomas; Hao Ying; Marvin Borja; Jonathan M Konel; Macey Henderson; Andrew M Cameron; Jacqueline M Garonzik-Wang; Dorry L Segev
Journal:  Clin Transplant       Date:  2018-06-15       Impact factor: 2.863

3.  Removing Disincentives to Kidney Donation: A Quantitative Analysis.

Authors:  Frank McCormick; Philip J Held; Glenn M Chertow; Thomas G Peters; John P Roberts
Journal:  J Am Soc Nephrol       Date:  2019-07-25       Impact factor: 10.121

4.  Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Authors:  Sebastian Przech; Amit X Garg; Jennifer B Arnold; Lianne Barnieh; Meaghan S Cuerden; Christine Dipchand; Liane Feldman; John S Gill; Martin Karpinski; Greg Knoll; Charmaine Lok; Matthew Miller; Mauricio Monroy; Chris Nguan; G V Ramesh Prasad; Sisira Sarma; Jessica M Sontrop; Leroy Storsley; Scott Klarenbach
Journal:  J Am Soc Nephrol       Date:  2018-11-07       Impact factor: 10.121

5.  The Change in Living Kidney Donation in Women and Men in the United States (2005-2015): A Population-Based Analysis.

Authors:  Jagbir Gill; Yayuk Joffres; Caren Rose; Julie Lesage; David Landsberg; Matthew Kadatz; John Gill
Journal:  J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 10.121

6.  Gender Disparities and Financial Barriers to Living Kidney Donation.

Authors:  Arthur J Matas; Rebecca E Hays
Journal:  J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 10.121

7.  Financial Neutrality in Organ Donation.

Authors:  Alexander M Capron; Francis L Delmonico; Gabriel M Danovitch
Journal:  J Am Soc Nephrol       Date:  2019-12-09       Impact factor: 10.121

8.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

9.  Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.

Authors:  Mary Amanda Dew; Zeeshan Butt; Qian Liu; Mary Ann Simpson; Jarcy Zee; Daniela P Ladner; Susan Holtzman; Abigail R Smith; Elizabeth A Pomfret; Robert M Merion; Brenda W Gillespie; Averell H Sherker; Robert A Fisher; Kim M Olthoff; James R Burton; Norah A Terrault; Alyson N Fox; Andrea F DiMartini
Journal:  Transplantation       Date:  2018-01       Impact factor: 4.939

10.  Assessing Living Donor Priorities Through Nominal Group Technique.

Authors:  Lindsey M Dorflinger; Sanjay Kulkarni; Carrie Thiessen; Sharon Klarman; Liana Fraenkel
Journal:  Prog Transplant       Date:  2017-12-15       Impact factor: 1.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.